NCT06652087

Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2024-09-02Est. Completion: 2026-09-30

Enrollment target: 40 participants

Locations

Moscow, Moscow, Russia

Contact

Konstantin Ivashkinivashkin_k_v@staff.sechenov.ru +7 926 213 58 33

Elena Bueverovabueverova_e_l@staff.sechenov.ru +7 916 526 6245

Other microbiome trials you might be interested in

Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical TrialRecruiting

Irritable Bowel SyndromeIrritable Bowel Syndrome With Diarrhea (IBS-D)Repetitive Transcranial Magnetic Stimulation (rTMS)Chronic DiarrheaIntestinal Flora

Objectives: This study aims to evaluate the clinical efficacy and safety of repetitive transcranial magnetic stimulation…

Suzhou, ChinaEst. completion Jul 1, 2026

View Trial →

A Trial of a Multi-Component Nutritional Supplement in Hydrogen-Dominant Small Intestinal Bacterial OvergrowthCompleted

Small Intestinal Bacterial Overgrowth Syndrome (SIBO)Small Intestinal Bacterial Overgrowth

The goal of this trial is to evaluate the safety and tolerability of an 8-week, multi-component nutritional supplement (…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.